389 related articles for article (PubMed ID: 22810206)
1. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis.
Enoiu M; Jiricny J; Schärer OD
Nucleic Acids Res; 2012 Oct; 40(18):8953-64. PubMed ID: 22810206
[TBL] [Abstract][Full Text] [Related]
2. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.
Hicks JK; Chute CL; Paulsen MT; Ragland RL; Howlett NG; Guéranger Q; Glover TW; Canman CE
Mol Cell Biol; 2010 Mar; 30(5):1217-30. PubMed ID: 20028736
[TBL] [Abstract][Full Text] [Related]
3. Structure-dependent bypass of DNA interstrand crosslinks by translesion synthesis polymerases.
Ho TV; Guainazzi A; Derkunt SB; Enoiu M; Schärer OD
Nucleic Acids Res; 2011 Sep; 39(17):7455-64. PubMed ID: 21666254
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links.
Zheng H; Wang X; Warren AJ; Legerski RJ; Nairn RS; Hamilton JW; Li L
Mol Cell Biol; 2003 Jan; 23(2):754-61. PubMed ID: 12509472
[TBL] [Abstract][Full Text] [Related]
5. Translesion DNA synthesis polymerases in DNA interstrand crosslink repair.
Ho TV; Schärer OD
Environ Mol Mutagen; 2010 Jul; 51(6):552-66. PubMed ID: 20658647
[TBL] [Abstract][Full Text] [Related]
6. Visualizing inhibition of nucleosome mobility and transcription by cisplatin-DNA interstrand crosslinks in live mammalian cells.
Zhu G; Song L; Lippard SJ
Cancer Res; 2013 Jul; 73(14):4451-60. PubMed ID: 23695549
[TBL] [Abstract][Full Text] [Related]
7. REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.
Sharma S; Canman CE
Environ Mol Mutagen; 2012 Dec; 53(9):725-40. PubMed ID: 23065650
[TBL] [Abstract][Full Text] [Related]
8. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells.
Nojima K; Hochegger H; Saberi A; Fukushima T; Kikuchi K; Yoshimura M; Orelli BJ; Bishop DK; Hirano S; Ohzeki M; Ishiai M; Yamamoto K; Takata M; Arakawa H; Buerstedde JM; Yamazoe M; Kawamoto T; Araki K; Takahashi JA; Hashimoto N; Takeda S; Sonoda E
Cancer Res; 2005 Dec; 65(24):11704-11. PubMed ID: 16357182
[TBL] [Abstract][Full Text] [Related]
9. The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links.
Al-Minawi AZ; Lee YF; Håkansson D; Johansson F; Lundin C; Saleh-Gohari N; Schultz N; Jenssen D; Bryant HE; Meuth M; Hinz JM; Helleday T
Nucleic Acids Res; 2009 Oct; 37(19):6400-13. PubMed ID: 19713438
[TBL] [Abstract][Full Text] [Related]
10. The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136.
Clingen PH; De Silva IU; McHugh PJ; Ghadessy FJ; Tilby MJ; Thurston DE; Hartley JA
Nucleic Acids Res; 2005; 33(10):3283-91. PubMed ID: 15944449
[TBL] [Abstract][Full Text] [Related]
11. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
Zhang N; Liu X; Li L; Legerski R
DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
[TBL] [Abstract][Full Text] [Related]
12. REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA).
Shen X; Jun S; O'Neal LE; Sonoda E; Bemark M; Sale JE; Li L
J Biol Chem; 2006 May; 281(20):13869-72. PubMed ID: 16571727
[TBL] [Abstract][Full Text] [Related]
13. DNA polymerase ζ is a major determinant of resistance to platinum-based chemotherapeutic agents.
Sharma S; Shah NA; Joiner AM; Roberts KH; Canman CE
Mol Pharmacol; 2012 Jun; 81(6):778-87. PubMed ID: 22387291
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks.
Zhao J; Jain A; Iyer RR; Modrich PL; Vasquez KM
Nucleic Acids Res; 2009 Jul; 37(13):4420-9. PubMed ID: 19468048
[TBL] [Abstract][Full Text] [Related]
15. Novel role of base excision repair in mediating cisplatin cytotoxicity.
Kothandapani A; Dangeti VS; Brown AR; Banze LA; Wang XH; Sobol RW; Patrick SM
J Biol Chem; 2011 Apr; 286(16):14564-74. PubMed ID: 21357694
[TBL] [Abstract][Full Text] [Related]
16. Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks.
Thoma BS; Wakasugi M; Christensen J; Reddy MC; Vasquez KM
Nucleic Acids Res; 2005; 33(9):2993-3001. PubMed ID: 15914671
[TBL] [Abstract][Full Text] [Related]
17. Targeting and processing of site-specific DNA interstrand crosslinks.
Vasquez KM
Environ Mol Mutagen; 2010 Jul; 51(6):527-39. PubMed ID: 20196133
[TBL] [Abstract][Full Text] [Related]
18. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
De Silva IU; McHugh PJ; Clingen PH; Hartley JA
Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
Chválová K; Brabec V; Kaspárková J
Nucleic Acids Res; 2007; 35(6):1812-21. PubMed ID: 17329374
[TBL] [Abstract][Full Text] [Related]
20. The differences between ICL repair during and outside of S phase.
Williams HL; Gottesman ME; Gautier J
Trends Biochem Sci; 2013 Aug; 38(8):386-93. PubMed ID: 23830640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
